Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding study.
| Autor: | Seiichiro Ozono, Taiji Tsukamoto, Seiji Naito, Yasuo Ohashi, Takeshi Ueda, Tsutomu Nishiyama, Hideki Maeda, Hidehito Kusuoka, Rio Akazawa, Mototsugu Ito, Hideyuki Akaza |
|---|---|
| Zdroj: | Japanese Journal of Clinical Oncology; May2017, Vol. 47 Issue 5, p438-446, 9p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|